| 11866444 |
Oxabicycloheptane prodrugs |
John S. Kovach, Robert A. Volkmann |
2024-01-09 |
$203,000 |
| 11236102 |
Oxabicycloheptane prodrugs |
John S. Kovach, Robert A. Volkmann |
2022-02-01 |
$717,000 |
| 11083711 |
Amine prodrugs of pharmaceutical compounds |
— |
2021-08-10 |
|
| 10618908 |
Oxabicycloheptane prodrugs |
John S. Kovach, Robert A. Volkmann |
2020-04-14 |
|
| 10435389 |
Octahydrocyclopenta[c]pyrrole allosteric inhibitors of SHP2 |
Robert A. Volkmann, Frederick Nelson, Panayiotis Zagouras |
2019-10-08 |
|
| 10364252 |
Oxabicycloheptane prodrugs |
John S. Kovach, Robert A. Volkmann |
2019-07-30 |
|
| 10072018 |
Compounds for treatment of pain |
Robert A. Volkmann, Peter Cornelius, Panayiotis Zagouras, Fredrick Raymond Nelson, Anton Fliri |
2018-09-11 |
|
| 10035813 |
Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
John J. Partridge, John Colucci, Yves Gareau, Michel Therien, Robert Zamboni +2 more |
2018-07-31 |
|
| 9988394 |
Oxabicycloheptane prodrugs |
John S. Kovach, Robert A. Volkmann |
2018-06-05 |
|
| 9487531 |
Compounds for treatment of pain |
Robert A. Volkmann, Peter Cornelius, Panayiotis Zagouras, Frederick Nelson, Anton Fliri |
2016-11-08 |
|
| 9180123 |
N-link hydroxamic acid derivatives useful as antibacterial agents |
Matthew Frank Brown, Ye Che, Michael J. Melnick, Justin Ian Montgomery, Usa Reilly |
2015-11-10 |
$341,611,000 |
| 9018384 |
N-link hydroxamic acid derivatives useful as antibacterial agents |
Matthew Frank Brown, Ye Che, Michael J. Melnick, Justin Ian Montgomery, Usa Reilly |
2015-04-28 |
$642,054,000 |
| 8901105 |
Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
John J. Partridge, John Colucci, Yves Gareau, Michel Therien, Robert Zamboni +2 more |
2014-12-02 |
|
| 8853258 |
C-linked hydroxamic acid derivatives useful as antibacterial agents |
Matthew Frank Brown, Michael Joseph Melnick, Usa Reilly |
2014-10-07 |
$301,901,000 |
| 8846933 |
N-link hydroxamic acid derivatives useful as antibacterial agents |
Matthew Frank Brown, Ye Che, Michael Joseph Melnick, Justin Ian Montgomery, Usa Reilly |
2014-09-30 |
$281,207,000 |
| 8664401 |
N-linked hydroxamic acid derivatives useful as antibacterial agents |
Matthew Frank Brown, Ye Che, Michael Joseph Melnick, Justin Ian Montgomery, Usa Reilly |
2014-03-04 |
$672,881,000 |
| 7795244 |
Penem prodrugs |
Katherine E. Brighty, Dale M. McLeod, John O'Donnell |
2010-09-14 |
$150,078,000 |
| 7795243 |
Penem prodrugs |
Katherine E. Brighty, Dale G. McLeod, John O'Donnell |
2010-09-14 |
$150,078,000 |
| 7354941 |
Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes |
Robert J. Chambers |
2008-04-08 |
$140,126,000 |
| 7250518 |
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes |
Thomas Victor Magee, Robert J. Chambers |
2007-07-31 |
$138,124,000 |
| 7183293 |
Ether derivatives useful as inhibitors of PDE4 isozymes |
Robert J. Chambers, Thomas Victor Magee |
2007-02-27 |
$200,898,000 |
| 7091197 |
Beta-lactamase inhibitor prodrug |
Dale G. McLeod |
2006-08-15 |
$248,275,000 |
| 7060717 |
Nicotinamide derivatives useful as PDE4 inhibitors |
Simon Bailey, Elisabeth Colette Louise Gautier, Alan John Henderson, Thomas Victor Magee, John Paul Mathias +3 more |
2006-06-13 |
$276,459,000 |
| 6953810 |
Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
Robert J. Chambers, Thomas Victor Magee |
2005-10-11 |
$495,540,000 |
| 6949573 |
Nicotinamide derivatives useful as PDE4 inhibitors |
Simon Bailey, Elisabeth Colette Louise Gautier, Alan John Henderson, Thomas Victor Magee, John Paul Mathias +3 more |
2005-09-27 |
$119,913,000 |
